GOLDENWELL BIOTECH, INC. (GWLL) Total liabilities 2019–2025
GOLDENWELL BIOTECH, INC. (GWLL) total liabilities at each fiscal year-end, per SEC filings.
$379,833FY2025 · since FY2019: $0 → $379,833
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $379,833 | +39.9% |
| FY2024 | $271,433 | +88.7% |
| FY2023 | $143,837 | +207.5% |
| FY2022 | $46,782 | -70.6% |
| FY2021 | $159,266 | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice